Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

Clinical trial NCT01229943 · COMPLETED

Trial details

NCT number: NCT01229943
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Neuroendocrine Tumor Locally Advanced Pancreatic Neuroendocrine Tumor Pancreatic Gastrinoma Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G2 Pancreatic Vipoma

Start date: 2010-10-15
Primary completion: 2014-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.